CSBR
Champions Oncology IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$79.85M
P/E Ratio
—
EPS
$-0.18
Beta
0.40
52W High
$9.63
52W Low
$5.50
50-Day MA
$6.18
200-Day MA
$6.73
Dividend Yield
—
Profit Margin
-4.04%
Forward P/E
22.88
PEG Ratio
0.00
About Champions Oncology Inc
Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. The company is headquartered in Hackensack, New Jersey.
Fundamentals
| Revenue (TTM) | $57.95M |
| Gross Profit (TTM) | $26.58M |
| EBITDA | -772,000 |
| Operating Margin | -1.13% |
| Return on Equity | -47.60% |
| Return on Assets | -4.70% |
| Revenue/Share (TTM) | $4.20 |
| Book Value | $0.31 |
| Price-to-Book | 19.97 |
| Price-to-Sales (TTM) | 1.38 |
| EV/Revenue | 1.438 |
| EV/EBITDA | 20.48 |
| Quarterly Earnings Growth (YoY) | -61.10% |
| Quarterly Revenue Growth (YoY) | -2.80% |
| Shares Outstanding | $13.89M |
| Float | $5.19M |
| % Insiders | 26.67% |
| % Institutions | 48.10% |
Historical Volatility
HV 10-Day
35.01%
HV 20-Day
53.14%
HV 30-Day
47.41%
HV 60-Day
52.43%
HV Rank
15.5%
Volatility is currently contracting
Data last updated: 4/10/2026